Vitamin D receptor-binding site variants affect prostate cancer progression.

about

Nutraceuticals in prostate cancer therapeutic strategies and their neo-adjuvant use in diverse populations Influence of vitamin D on cancer risk and treatment: Why the variability?

P2860

Q57109257-43420274-036E-4C9D-86F4-FBDC0687E0F1 Q58133485-DFA60A99-037F-4609-9D81-6F0EC4D7310C

P2860

Vitamin D receptor-binding site variants affect prostate cancer progression.

Item

http://www.wikidata.org/entity/Q47110997

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Vitamin D receptor-binding site variants affect prostate cancer progression.

@en

Vitamin D receptor-binding site variants affect prostate cancer progression.

@nl

type

Item

label

Vitamin D receptor-binding site variants affect prostate cancer progression.

@en

Vitamin D receptor-binding site variants affect prostate cancer progression.

@nl

prefLabel

Vitamin D receptor-binding site variants affect prostate cancer progression.

@en

Vitamin D receptor-binding site variants affect prostate cancer progression.

@nl

P1476

Vitamin D receptor-binding site variants affect prostate cancer progression.

@en

P2093

Bo-Ying Bao

http://www.w3.org/2001/XMLSchema#string

Cheng-Hsueh Lee

http://www.w3.org/2001/XMLSchema#string

Chia-Cheng Yu

http://www.w3.org/2001/XMLSchema#string

Hsin-Ling Yin

http://www.w3.org/2001/XMLSchema#string

Huei-Ju Ting

http://www.w3.org/2001/XMLSchema#string

Shu-Pin Huang

http://www.w3.org/2001/XMLSchema#string

Ta-Yuan Chang

http://www.w3.org/2001/XMLSchema#string

Te-Ling Lu

http://www.w3.org/2001/XMLSchema#string

Tsung-Yi Huang

http://www.w3.org/2001/XMLSchema#string

Victor C Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

The UCSC Table Browser data retrieval tool

Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer.

Program-specific distribution of a transcription factor dependent on partner transcription factor and MAPK signaling.

The International HapMap Project Web site.

Oligosaccharyltransferase isoforms that contain different catalytic STT3 subunits have distinct enzymatic properties.

Do sunlight and vitamin D reduce the likelihood of colon cancer?

Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancer.

β2-microglobulin induces epithelial to mesenchymal transition and confers cancer lethality and bone metastasis in human cancer cells.

Genetic variants of the autophagy pathway as prognostic indicators for prostate cancer.

P304

74119-74128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.18271

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chao-Yuan Huang

P577

2017-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29088772

http://www.w3.org/2001/XMLSchema#string

P921

vitamin D

P932

5650327

http://www.w3.org/2001/XMLSchema#string

Vitamin D receptor-binding site variants affect prostate cancer progression.

about

P2860

P2860

Vitamin D receptor-binding site variants affect prostate cancer progression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932